RxDoctor Payments Data

Matthew Dacosta, PA

Physician Assistant · Providence, RINPI 1093201667

Payments from drug & device makers

$2,103in general payments, 2019–2025

Across 109 payments — averaging $19.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$307
  • AbbVie$288
  • AstraZeneca$280
  • Nestle Healthcare Nutrition Inc.$162
  • GSK$150
  • Teva Pharmaceuticals USA, Inc.$150
  • plus $766 from 15 others

What the payments were for

  • Food & beverage$2,103100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,103 in reported general payments places this provider in the 85th percentile of 481 physician assistant providers in Rhode Island.

See all physician assistant providers in Rhode Island

Medicare billing

Part B allowed, 2024
$24,267
Medicare patients
133
Services billed
612

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
WegovySemaglutide12$15,214
FarxigaDapagliflozin Propanediol19$15,006
EliquisApixaban19$14,823
OzempicSemaglutide11$11,622
Metformin Hcl48$1,971
Atorvastatin Calcium142$1,691
Rosuvastatin Calcium97$1,492
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,490
Nano 2nd Gen Pen NeedlePen Needle, Diabetic20$1,401
Omeprazole61$1,082
Lisinopril110$1,061
SynthroidLevothyroxine Sodium11$871
Simvastatin49$842
Amlodipine Besylate107$749
Escitalopram Oxalate38$730

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskWegovy, Ozempic$307$26,83623 claims
AstraZenecaFarxiga$280$15,00619 claims
PfizerEliquis$119$14,82319 claims
AbbVieSynthroid$288$87111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 481 physician assistant providers in Rhode Island.

Other physician assistant in Providence

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →